Table 2 Demographics and clinical features of FTD syndromes

Women, n (%)

232 (52.2)

0

< 0.001

68 (57.6)

57.6

0.01

68 (54)

0

< 0.001

13,162 (69.9)

0

Age at first visit, m (sd)

69.4 (10.3)

0

< 0.001

72.7 (9.5)

0

< 0.001

72.0 (8.0)

0

< 0.001

80.6 (7.5)

0

Age at diagnosis, m (sd)

70.2 (10.3)

0

< 0.001

73.6 (9.7)

0

< 0.001

72.8 (8.1)

0

< 0.001

81.0 (7.3)

0

Delay referral (months), m (sd)

40.0 (41.2)

87

< 0.001

30.8 (20.5)

19

0.84

35.8 (29.9)

24

0.13

31.8 (32.0)

5370

Diagnosis wandering (months), m (sd)

9.9 (16.8)

0

< 0.001

10.5 (16.4)

0

< 0.001

9.1 (15.1)

0

< 0.001

5.8 (14.2)

0

Clinical follow-up (months), m (sd)

25.2 (24.0)

0

< 0.001

24.2 (22.0)

0

< 0.001

20.2 (19.6)

0

0,05

17.5 (21.4)

0

Dementia family history, n (%)

75 (16.8)

0

< 0.001

11 (9.3)

0

< 0.001

13 (10.3)

0

< 0.001

508 (2.7)

0

MMSE at first visit, m (sd)

22.1 (6.1)

117

0.02

20.6 (7.5)

27

0.002

21.9 (6.1)

38

< 0.001

18.9 (6.0)

2246

IADL-4, median

3

199

< 0.001

4

38

< 0.001

3

54

< 0.001

2

6689

PET in the network, n (%)

117 (26.2)

0

< 0.001

18 (15.2)

0

< 0,001

25 (19.8)

0

< 0.001

484 (2.5)

0

CSF in the network, n (%)

135 (30.3)

0

< 0.001

22 (18.6)

0

< 0,001

33 (26.2)

0

< 0.001

759 (3.9)

0

Death, n (%)

213 (48.4)

0

63 (53.4)

0

96 (76.2)

0

11,220 (59.1)

0

Survival in years, median

6.5

0

0.18

6.1

0

0.14

4.0

0

< 0.001

5.5

0

Autopsy verification, n (%)

4 (0.8)

0

0 (0)

0

5 (4.0)

0

6 (0.03)

0